Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2012


2nd Reverse Phase Protein Array Global Workshop

12 Nov 2012 - 13 Nov 2012 - Edinburgh, Scotland, UK



Bookmark and Share


Key Workstreams;

  • Challenges, needs, advantages and disadvantages associated with printing and detection
  • Image acquisition, data processing and normalization
  • Validating and sharing of Antibody data
  • Alignment with "Proteomics Standard Initiative" (PSI) at HUPO
  • New technologies showcase
  • Pharmaceutical Discovery applications
  • RPPA in management and analysis of clinical samples
  • How to use RPA Data in the Clinic (i.e. PD Marker, Prognostic Marker and Predictive Marker):
  • Launch : Global RPPA Society


The evolution of Reverse Phase Protein Array (RPPA ) technologies has facilitated the application of high-throughput functional proteomics in patient samples and preclinical drug screening with improved sensitivity and quantification to support the identification and analysis of post-translational biomarkers and pathway networks.

Advancing RPPA technology into mainstream basic research, drug discovery and clinical diagnostics applications will require improved consistency in methods and an expanded portfolio of validated antibody reagents and procedures that can be shared across the community.

Hosted by the University of Edinburgh, the second Reverse Phase Protein Array Global Workshop will bring together scientists from both academia and industry to discuss the latest technical advances and standards for generating and analysing results using Reverse Phase Protein Arrays.

The 2012 workshop shall also be used to launch a global RPPA society to support communication, data-sharing and ambitions of the RPPA community.



Further information
Scientific News
Retractable Protein Nanoneedles
The ability to control the transfer of molecules through cellular membranes is an important function in synthetic biology; a new study from researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering and Harvard Medical School (HMS) introduces a novel mechanical method for controlling release of molecules inside cells.
A Crystal Clear View of Biomolecules
Fundamental discovery triggers paradigm shift in crystallography.
Charting Kidney Cancer Metabolism
Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.
"Dark Side" of the Transcriptome
New approach to quantifying gene "read-outs" reveals important variations in protein synthesis and has implications for understanding neurodegenerative diseases.
Advancing Synthetic Biology
Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Pumpjack" Mechanism for Splitting and Copying DNA
High-resolution structural details of cells' DNA-replicating proteins offer new insight into how these molecular machines function
The Power of Three
Overlooked portion of cell “death receptor” critical in some cancers, autoimmune diseases.
Biomarker for Recurring HPV-Linked Oropharyngeal Cancers
A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!